CANADIAN AND INTERNATIONAL PERSPECTIVES ON LATE BREAKING CLINICAL TRIALS

Thursday, October 26, 2023

16:30 – 17:30 EST

Location: Palais, 517D

Target Audience: General: All cardiovascular (clinical and research) health professionals

Co-Chair(s)

Jacob Udell, MD, MPH

Cardiology Division Head
Women's College Hospital
University of Toronto
Shelley Zieroth, MD

Heart Failure Cardiologist, Past President CHFS
St. Boniface Hospital
University of Manitoba

Disclosure(s):

Jacob A. Udell, MD, MPH: Boehringer Ingelheim: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novovax: Consultant/Advisory Board (Terminated, December 8, 2022); Sanofi: Consultant/Advisory Board (Terminated, May 16, 2022)

Shelley Zieroth, MD: Astra Zeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); BMS: Consultant/Advisory Board (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Cytokinetics: Consultant/Advisory Board (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); GSK: Consultant/Advisory Board (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Merck: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing); Otsuka: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Roche: Speaker/Honoraria (Ongoing); Servier: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Vifor: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Presentations:

16:30 – 16:38 EST

FIRE TRIAL: COMPLETE OR CULPRIT-ONLY PCI IN OLDER PATIENTS WITH MYOCARDIAL INFARCTION PRESENTATION
Presenter: Gianluca Campo, MD, PhD – University of Ferrara
16:38 – 16:42 EST

FIRE TRIAL: COMPLETE OR CULPRIT-ONLY PCI IN OLDER PATIENTS WITH MYOCARDIAL INFARCTION - DISCUSSION
Presenter: Alexandra Bastiany, MD – Thunder Bay Regional Health Sciences Centre
Presenter: Gianluca Campo, MD, PhD – University of Ferrara
16:42 – 16:50 EST

THE FRAIL-AF RCT: SAFETY OF SWITCHING FROM A VITAMIN K ANTAGONIST TO A NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANT IN FRAIL OLDER PATIENTS WITH ATRIAL FIBRILLATION PRESENTATION
Presenter: Sander van Doorn – UMC Utrecht
16:50 – 16:54 EST

THE FRAIL-AF RCT: SAFETY OF SWITCHING FROM A VITAMIN K ANTAGONIST TO A NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANT IN FRAIL OLDER PATIENTS WITH ATRIAL FIBRILLATION DISCUSSION
Presenter: Atul Verma, MD – McGill University Health Centre
16:54 – 17:02 EST

COP-AF: COLCHICINE FOR THE PREVENTION OF PERIOPERATIVE ATRIAL FIBRILLATION AFTER MAJOR THORACIC SURGERY PRESENTATION
Presenter: David Conen, MD MPH – McMaster University
17:02 – 17:06 EST

COP-AF: COLCHICINE FOR THE PREVENTION OF PERIOPERATIVE ATRIAL FIBRILLATION AFTER MAJOR THORACIC SURGERY DISCUSSION
Presenter: Jean-Claude Tardif – MHI Research Center
17:06 – 17:14 EST

STEP HFPEF: SEMAGLUTIDE IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY PRESENTATION
Presenter: Subodh Verma, MD, PhD (he/him/his) – CSCS
17:14 – 17:18 EST

STEP HFPEF: SEMAGLUTIDE IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY DISCUSSION
Presenter: Zaine Albalawi – Newfoundland and Labrador Health Services
17:18 – 17:30 EST

Q&A
Co-Chair: Jacob A. Udell, MD, MPH – Women's College Hospital
Co-Chair: Shelley Zieroth, MD – St. Boniface Hospital